Stock Movers: Hershey Rises on Upgrade, Hims & Hers Drops on FDA Letter, WBD Falls After Downgrade

Hershey's Stock Surge on Analyst Upgrade

• 🍫 Hershey's (HSY) shares closed over 4% higher, driven by an upgrade from Goldman Sachs and a recent upgrade from BMP Paribar.
• 📈 Goldman Sachs cited improving market-share trends and incremental tailwinds for the chocolate and confectionery company, setting a price target of $222.
• 💰 The company's recent price hikes are being accepted by consumers, and cost pressures from tariffs and cocoa prices are understood and reflected in expectations.
• 📊 Hershey's is up 14% year-to-date, indicating strong investor optimism.

Hims & Hers Health Faces FDA Scrutiny

• 📉 Hims & Hers Health (HIMS) shares closed down nearly 6% after the FDA sent a warning letter regarding the company's marketing claims for compounded semaglutide products.
• ⚠️ The FDA's letter focused on the false or misleading claims about compounded drugs, which are cheaper alternatives to FDA-approved medications.
• 📢 This action follows broader FDA efforts to curb deceptive promotions, highlighted by a Super Bowl commercial for a copycat drug.
• 📊 Despite a triple-digit year-to-date gain (110%), investor concerns are rising, with over 40% of the float being short.

Warner Bros. Discovery Stock Declines Post-Downgrade

• 🎬 Warner Bros. Discovery (WBD) shares fell 6% following a downgrade by TD Cowen from 'buy' to 'hold'.
• 📉 The downgrade was prompted by the stock's rally beyond TD Cowen's $14 price target, fueled by unsubstantiated reports of Paramount potentially bidding for the company.
• ⚠️ TD Cowen highlighted the speculative nature of the rally and an elevated risk profile, suggesting shares could fall to $11-$12 if a bid doesn't materialize.
• ⚖️ Concerns about regulatory scrutiny and the financial implications of a potential merger between Paramount and WBD were also noted, with Elizabeth Warren expressing opposition to a concentration of media power.